Issue: July 2012
July 01, 2012
1 min read
Save

ADVANCE III

Issue: July 2012
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Primary endpoint was to demonstrate a 20% reduction of ventricular therapies delivered for treating spontaneous arrhythmia episodes with a fast cycle length.


ADVANCE-III